Novo’s Canned Heart Disease Trials, Novartis' Clinical Setbacks, and the Initial Approval for Alexander Disease

Novo’s Canned Heart Disease Trials, Novartis’ Clinical Setbacks, and the Initial Approval for Alexander Disease